Literature DB >> 18624715

Transient elastography: Applications and limitations.

Kentaro Yoshioka1, Naoto Kawabe, Senju Hashimoto.   

Abstract

Transient elastgraphy with use of FibroScan is one of most accurate methods for assessment of liver fibrosis. FibroScan can be readily used with an operator with a short training. In many different studies, liver stiffness measured by transient elastgraphy correlates well with fibrosis stages, and cutoff values of liver stiffness for fibrosis staging are similar even among different diseases. However there is wide variation of stiffness values in the same fibrosis stage, and some overlap between the adjacent stages. In addition, inflammatory activity and size of nodule of cirrhosis affect the liver stiffness values. The reproducibility may be reduced by age, obesity, steatosis, narrow intercostal space and lower degrees of hepatic fibrosis in patients. Thus the estimation of fibrosis stages from liver stiffness should be cautiously done. To improve the accuracy of liver fibrosis staging, the combination of transient elastography with other noninvasive methods such as FibroTest should be required.

Entities:  

Year:  2008        PMID: 18624715     DOI: 10.1111/j.1872-034X.2008.00386.x

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  11 in total

1.  Reduction of liver stiffness by antiviral therapy in chronic hepatitis B.

Authors:  Keisuke Osakabe; Naohiro Ichino; Toru Nishikawa; Hiroko Sugiyama; Miho Kato; Shiho Kitahara; Senju Hashimoto; Naoto Kawabe; Masao Harata; Yoshifumi Nitta; Michihito Murao; Takuji Nakano; Hiroaki Shimazaki; Yuko Arima; Koji Suzuki; Kentaro Yoshioka
Journal:  J Gastroenterol       Date:  2011-08-06       Impact factor: 7.527

2.  Visualising liver fibrosis by phase-contrast X-ray imaging in common bile duct ligated mice.

Authors:  Xi Zhang; Xin-Rong Yang; Yu Chen; Hai-Qing Li; Rui-Min Li; Qing-Xi Yuan; Pei-Ping Zhu; Wan-Xia Huang; Wei-Jun Peng
Journal:  Eur Radiol       Date:  2012-08-19       Impact factor: 5.315

Review 3.  Is transient elastography a useful tool for screening liver disease?

Authors:  Paolo Del Poggio; Silvia Colombo
Journal:  World J Gastroenterol       Date:  2009-03-28       Impact factor: 5.742

4.  Liver-spleen axis, insulin-like growth factor-(IGF)-I axis and fat mass in overweight/obese females.

Authors:  Silvia Savastano; Carolina Di Somma; Genoveffa Pizza; Annalba De Rosa; Valeria Nedi; Annalisa Rossi; Francesco Orio; Gaetano Lombardi; Annamaria Colao; Giovanni Tarantino
Journal:  J Transl Med       Date:  2011-08-16       Impact factor: 5.531

5.  Sparse logistic regression for diagnosis of liver fibrosis in rat by using SCAD-penalized likelihood.

Authors:  Fang-Rong Yan; Jin-Guan Lin; Yu Liu
Journal:  J Biomed Biotechnol       Date:  2011-06-01

6.  A Preliminary Investigation of Normal Pancreas and Acute Pancreatitis Elasticity Using Virtual Touch Tissue Quantification (VTQ) Imaging.

Authors:  Juan Xie; Liling Zou; Minghua Yao; Guang Xu; Lixia Zhao; Huixiong Xu; Rong Wu
Journal:  Med Sci Monit       Date:  2015-06-11

7.  Microfibrillar-Associated Protein 4: A Potential Biomarker for Screening for Liver Fibrosis in a Mixed Patient Cohort.

Authors:  Susanne Gjørup Sækmose; Belinda Mössner; Peer Brehm Christensen; Kristoffer Lindvig; Anders Schlosser; René Holst; Torben Barington; Uffe Holmskov; Grith Lykke Sorensen
Journal:  PLoS One       Date:  2015-10-13       Impact factor: 3.240

8.  The factors associated with longitudinal changes in liver stiffness in patients with chronic hepatitis B.

Authors:  In Ku Yo; Oh Sang Kwon; Jin Woong Park; Jong Joon Lee; Jung Hyun Lee; In Sik Won; Sun Young Na; Pil Kyu Jang; Pyung Hwa Park; Duck Joo Choi; Yun Soo Kim; Ju Hyun Kim
Journal:  Clin Mol Hepatol       Date:  2015-03-25

9.  Diffusion Weighted MRI for Hepatic Fibrosis: Impact of b-Value.

Authors:  Huseyin Ozkurt; Firat Keskiner; Ozan Karatag; Canan Alkim; Sukru Mehmet Erturk; Muzaffer Basak
Journal:  Iran J Radiol       Date:  2014-01-30       Impact factor: 0.212

10.  Cyclooxygenase-2 Inhibitor Reduces Hepatic Stiffness in Pediatric Chronic Liver Disease Patients Following Kasai Portoenterostomy.

Authors:  Hye Kyung Chang; Eun Young Chang; Seonae Ryu; Seok Joo Han
Journal:  Yonsei Med J       Date:  2016-07       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.